Searchable abstracts of presentations at key conferences in endocrinology

ea0028p249 | Pituitary | SFEBES2012

Observational analysis of local protocol for screening for hypoadrenalism post pituitary surgery

Smith Christopher , Kernohan Andrew

Background: Adrenal insufficiency is a common complication of pituitary surgery. We screen for hypoadrenalism with a day 4 morning cortisol. If < 400 nmol/l the patient is prescribed steroid replacement. Patients have a follow up short synacthen test at 6 weeks to assess the hypothalamic-pituitary-adrenal axis. We wanted to ensure the threshold of 400 nmol/l stopped patients with/or developing hypoadrenalism being discharged without glucocorticoid replacement. We also want...

ea0086p366 | Thyroid | SFEBES2022

Use of Burch-Wartofsky score when assessing the severity of hyperthyroidism, a retrospective study

Vennard Hannah , Duvieusart Ysaline , McNeilly Jane , Kernohan Andrew

Introduction: Thyroid storm, a life-threatening endocrine emergency, requires prompt intervention and treatment to improve outcomes. The diagnosis is made clinically, based on symptoms including hyperpyrexia, tachycardia, nausea, diarrhoea and altered cognition. The Burch-Wartofsky (BW) score is a symptom-based score recommended to determine the likelihood of thyroid storm. This retrospective study aims to determine use of the BW scale and its effect on management.<p class...

ea0004oc31 | Neuroendocrinology and diabetes | SFE2002

EFFECT OF COMBINED HORMONE REPLACEMENT THERAPY ON GLUCOSE METABOLISM IN POSTMENOPAUSAL WOMEN WITH TYPE 2 DIABETES; A RANDOMISED CONTROLLED TRIAL

Kernohan A , Lumsden M , Cleland S , Petrie J , Connell J

Prescription rates for HRT in women with type 2 diabetes are low. One reason for this is concern about adverse metabolic effects although evidence on this is limited. We report results from a 3-month randomised, double blind, placebo-controlled trial of 1mg 17-beta oestradiol combined with 0.5 mg norethisterone acetate in postmenopausal women with type 2 diabetes. The study has full local ethics committee approval.29 subjects entered the study; 1 taking ...

ea0004dp23 | Diabetes, metabolism and cardiovascular | SFE2002

EFFECT OF COMBINED HORMONE REPLACEMENT THERAPY ON GLUCOSE METABOLISM IN POSTMENOPAUSAL WOMEN WITH TYPE 2 DIABETES; A RANDOMISED CONTROLLED TRIAL

Kernohan A , Lumsden M , Cleland S , Petrie J , Connell J

Prescription rates for HRT in women with type 2 diabetes are low. One reason for this is concern about adverse metabolic effects although evidence on this is limited. We report results from a 3-month randomised, double blind, placebo-controlled trial of 1mg 17-beta oestradiol combined with 0.5 mg norethisterone acetate in postmenopausal women with type 2 diabetes. The study has full local ethics committee approval.29 subjects entered the study; 1 taking ...